Evaluating pediatric influenza vaccines in 2022–2023 — Providing optimal protection for the pediatric population — for Physicians

CAN-eng

$0

gratuit

Non accrédité

1 heure

Pediatrics

0 Crédits

This course is expired! Browse All Courses
APPRENDRE ENCORE PLUS

Description du cours

Influenza vaccination remains a critical public health tool to reduce outbreaks of endemic influenza infection. This program summarizes the key National Advisory Committee on Immunization (NACI) influenza vaccine recommendations and the differences between currently marketed vaccines in Canada. The overall goal of this program is to increase clinicians’ confidence in applying the NACI recommendations for pediatric influenza immunization for the 2022–2023 influenza season.

This program is made possible through educational support from CSL Seqirus.

Détails du cours

Date d'expiration : 2023-12-31

Métiers: Médecin

Faculté

Dr. Mark Loeb, MD, M.Sc, FRCPC
Dr. Anas Nseir, MD, FCFP, B.Pharm
Dr. Chandi Chandrasena, MD, CCFP, FCFP
Dr. Vivien Brown, MDCM, CCFP, FCFP, NCMP
Sherilyn Houle, MSP, PhD, CTH, AFTM RCPS (Glasg)
Carlene Oleksyn, B.S.P., R.Ph, CTH, CDE

Accréditation

<!--

This Self-Learning program has been certified by the College of Family Physicians of Canada for up to 1.0 Mainpro+ Credit(s).

Cert+ Program ID#: 197744

-->

Objectif(s) d'apprentissage

Upon completion of this continuing education program participants will be better able to:
  • Review the pediatric burden of disease in the coming 2022–2023 influenza season — notably, the severe underrepresentation in the pediatric population, including those at high risk of influenza infection and complications.
  • Identifier the influenza immunization options available to the pediatric population, including a review of relevant studies pertaining to different vaccines.
  • Reconnaître the potential for egg adaptation in the influenza vaccine manufacturing process.
  • Explorer the level of egg adaptation in recent years and its impact on vaccine effectiveness.
  • Examine new technologies that prevent egg adaptation (e.g., mammalian cell production).
This course is expired! Browse All Courses